MITRO, founded in 2012, is the first molecular imaging CRO company in China.
By applying Radiolabeling and Molecular Imaging techniques, MITRO provides outstanding services including preclinical and clinical drug screening, bio-distribution, pharmacokinetics and pharmacodynamics. MITRO can provide one-stop service for radiopharmaceuticals including in vitro discovery, radiochemistry, pre-clinical study, clinical study and registration.
By applying Radiolabeling and Molecular Imaging techniques, MITRO provides outstanding services including preclinical and clinical drug screening, bio-distribution, pharmacokinetics and pharmacodynamics. MITRO can provide one-stop service for radiopharmaceuticals including in vitro discovery, radiochemistry, pre-clinical study, clinical study and registration.